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Trypanosomes evade antibody-mediated lysis via antigenic variation and rapid antibody removal
from their cell surface. Recently, in Cell, Engstler et al. (2007) have discovered the mechanism for
antibody clearance. Hydrodynamic forces generated by trypanosome swimming create a current,
causing surface-bound antibodies to act as ‘‘molecular sails.’’ Consequently, they are swept to the
cell posterior, internalized via the flagellar-pocket, and degraded. Hydrodynamic sorting is a novel
biological process, possibly applicable in other contexts.It has long been appreciated that
African trypanosomes are a poor tar-
get for vaccine development due to
their capacity for immune evasion.
The dominant mechanism is antigenic
variation, whereby a homogeneous
variant surface glycoprotein (VSG)
coat is expressed on the trypanosome
cell surface. The densely packed VSG
homodimers prevent access of host
antibodies to underlying invariant sur-
face proteins, thus shielding them
from the immune response. In a para-
digm of antigenic variation, a small
proportion of trypanosomes ‘‘switch’’
VSG expression, thereby escaping
the lytic immune response directed to
the original antigen type (McCulloch,
2004). The basis of the loosely ordered
hierarchy of antigen switching is still
not fully understood. However, it is
not driven by the host immune re-
sponse but, rather, by distinct VSG
gene activation frequencies and by
the population dynamics of the two
morphological forms of the trypano-
some in the bloodstream, slender and
stumpy forms (Lythgoe et al., 2007).
These differ in proportion during the
course of each wave of parasitaemia,
with proliferative slender cells giving
way to nonproliferative stumpy cells
in a density-dependent manner. The
slender cells maintain the parasitae-
mia and provide the source of new an-
tigenic variants, whereas the stumpy
forms appear to be adapted for trans-
mission, prolonging their longevity inthe face of the developing immune
response in order to maximize their
opportunity for uptake by the para-
site’s vector, the tsetse fly (Matthews,
2005).
In addition to antigenic variation, try-
panosomes have a very high rate of
endocytosis that allows removal of
VSG-bound antibody and thus some
evasion of the initial immune response
during each wave of parasitaemia. The
entire VSG surface coat is recycled
through the endocytic system every
12.5 min, with all endocytosis occur-
ring via a specialized organelle called
the flagellar pocket, located in the pos-
terior of the cell (Engstler et al., 2004).
Laundering of antibody-bound VSG
extends the survival time of individual
parasites as the antibody response
develops by preventing complement
activation and formation of the mem-
brane attack complex. However, as
the immune response continues to
mount, this system is overwhelmed,
and cells with antibody-bound VSG
are lysed by complement, and only
those that have switched survive.
By staining of surface VSG with fluo-
rescent dye, Engstler et al. (2007) de-
veloped a method to track antibody
clearance from the cell in real time.
They found that antibody clearance
was rapid (much more so than previ-
ously thought) and occurred in three
steps, each with different sensitivities
to temperature: (1) accumulation of
the antibody complex at the posteriorCell Host & Microbe 2, Nof the cell, (2) entry into the flagellar
pocket, and (3) endocytosis, where-
after the VSG is recycled and the anti-
body is degraded. Stumpy cells also
cleared antibody more rapidly than
slender cells. This matches expecta-
tion: it has been known for many years
that the stumpy forms are particularly
resistant to antibody-mediated lysis
(Balber, 1972), such that they survive
at least seven times longer at an equiv-
alent antibody titer than slender forms
(McLintock et al., 1993). This is pro-
posed to be mediated by their high
rate of endocytosis compared to
slender forms (though this is debated;
Natesan et al., 2007), with bound anti-
body being rapidly trafficked via their
enlarged flagellar pocket.
To further investigate the mecha-
nism of antibody clearance, Engstler
et al. (2007) used RNAi-mediated tran-
script ablation to systematically inac-
tivate trypanosome endocytosis (by
targeting clathrin), plasma membrane
recycling (by targeting actin), or cell
motility. When clathrin was targeted,
the inhibition of endocytosis caused
bound antibody to accumulate on the
surface, such that parasites showed
enhanced sensitivity to complement
lysis. Nonetheless, posterior accumu-
lation was retained. Similarly, when
actin was removed, the parasites re-
tained the ability to redistribute bound
immunoglobulin (Ig) and to clear anti-
body-VSG complexes from their sur-
face. This ruled out antibody ‘‘towing’’ovember 2007 ª2007 Elsevier Inc. 279
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PreviewsFigure 1. Schematic of Antibody Clearance from the Trypanosome Surface by
Hydrodynamic Flow Forces
(A) Schematic representation of the African trypanosome. Anterior-directed motion of the parasite
generates hydrodynamic flow forces that direct surface-bound antibody toward the posterior
of the cell. Here, the VSG-antibody complex is internalized via the flagellar pocket, with antibody
being directed to the lysosome, whereas VSG is recycled to the parasite surface.
(B) VSG (represented as vertical pillars) is attached to the parasite membrane via a glycosylphos-
phatidylinositol (GPI) anchor, forming a homogenous coat on the parasite surface. The GPI anchor
enables free migration within the lipid bilayer, facilitating molecular flow. Antibodies bind to the
VSG and are sorted via hydrodynamic flow forces, with larger molecules (IgM) moving more rapidly
than smaller molecules (IgG), as indicated by the relative arrow size.to the cell posterior by plasma mem-
brane recycling or motor protein-
driven movement. Most tellingly, how-
ever, inhibiting parasite motility by
detaching the flagellum from the cell
body via ablation of the flagellum
adhesion glycoprotein, fla1, caused
a loss of antibody-VSG complex sort-
ing to the cell posterior, thereby pre-
venting the first step in antibody clear-
ance. This suggested that it was the
action of swimming itself that provided
the motive force for the immune com-
plexes to locate to the posterior of
the cell, which was then removed by
active endocytosis via the flagellar
pocket (Figure 1A).
To challenge their hypothesis, Engs-
tler et al. (2007) targeted an axone-
mal dynein arm component, DNAI1.
DNAI1 ablation has previously been
shown to cause the flagellar beat to
reverse polarity, causing the trypano-
some to swim backward (Branche
et al., 2006). Crucially, and consistent
with their hypothesis, when the try-
panosome reversed direction the anti-
body-VSG complex accumulated at
the opposite, anterior, end of the cell
away from the flagellar pocket.280 Cell Host & Microbe 2, November 20The proposal that physical flow
forces caused bound macromolecules
to be swept posteriorly on the swim-
ming trypanosome suggested that
the size of the bound ligand might af-
fect its rate of migration. Consistent
with this, larger ligands (e.g., IgM
pentamers versus the IgG monomer)
acted as better ‘‘sails,’’ were more
prone to ‘‘catching’’ the hydrodynamic
forces generated by the cell swim-
ming, and were consequently cleared
from the cell more quickly (Engstler
et al., 2007) (Figure 1B). Moreover,
clearance was more effective in vis-
cous medium such as blood and was
predicted to be more rapid in confined
spaces, such as capillaries.
Although effective, the protective
effect observed is likely short lived:
increasing the number of VSG mole-
cules bound with IgG increased the
viscosity of the membrane through
molecular crowding, consequently de-
creasing the rate of antibody clear-
ance (Engstler et al., 2007). The biolog-
ical implications of this are clear: as the
immune response becomes stronger,
the cell becomes less efficient at deal-
ing with it. Hence, understanding the07 ª2007 Elsevier Inc.dynamics of the changes in antibody
titer (and isoform) and subsequent
clearance during each parasitaemia
will be a key factor in establishing just
how much benefit this mechanism
can be to the trypanosome. In other
words, how much time does flow-
mediated antibody sorting ‘‘buy’’ the
trypanosome in its battle against the
immune system? This is important
information necessary to evaluate the
overall biological significance of the
phenomenon to the parasite, where
other variables such as VSG switch
frequency, differing antibody titers
within diverse body compartments,
and the potential for parasite-induced
immunomodulation or influences on
parasite virulence (e.g., Webb et al.,
1997) might also play a part. A clear
benefit of the present study, however,
is its accessibility to further investiga-
tion and modeling. For example, the
differential flow and clearance of IgG
and IgM makes clear predictions for
parasite survival when growth in IgM
knockout or wild-type mice is com-
pared, with likely additional conse-
quences for the balance of slender
and stumpy cells in the resulting
parasitaemias.
By demonstrating the concept of us-
ing molecular sails to facilitate antibody
clearance, the work of Engstler et al.
further highlights the eleganceof the im-
mune evasion mechanisms employed
by African trypanosomes as they bal-
ance longevity in the bloodstream with
transmissibility to the tsetse fly. Clearly,
there is much still to be learned in the
complex interplay between the mech-
anisms of host immunity (including
antibody-mediated cellular defenses),
parasite immune evasion, density-
dependent modulation of the parasitae-
mia, and transmissibility. It has yet to be
determined whether this model can be
applied to other systems, but Engstler
et al. speculate that flow-forced sorting
of proteins could be a general organiz-
ing principle in numerous biological
contexts.
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CCR5 has been suborned as an entry
coreceptor by primate immunodefi-
ciency viruses (PIV), most notably
HIV-1 (human immunodeficiency virus
type 1). The viral gp120 glycoproteins
bind CCR5 during the events that
drive fusion of the virus and cell mem-
branes, leading to infection (Hart-
ley et al., 2005). CCR5 was probably
the sole receptor for the primordial
PIV from which present-day viruses
evolved, but acquiring the ability to
use CD4 (cluster of differentiation 4)
as a primary receptor prior to CCR5
binding quite plausibly provided ad-
vantages to PIVs. By serving as a
high-affinity binding site on target
cells, CD4 speeds infection, and it
also allows the highly conserved CCR5
site on gp120 to remain shielded
from neutralizing antibodies until too
little time and space remain for suc-
cessful intervention. Hence, CCR5
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the rate of progression of HIV-1-in-
fected individuals to acquired immu-
nodeficiency syndrome (AIDS) and
death. CCR5 expression varies be-
tween individuals, principally because
of sequence variations, within its pro-
moter, that affect protein production;
the less CCR5 expressed, the slower
disease progresses. Moreover, a rare,
protein-inactivating mutation, CCR5-
D32, strongly protects against acqui-
sition of HIV-1 infection by homo-
zygous individuals (heterozygotes are
not protected, but progress to disease
less rapidly) (Kuhmann and Hartley,
2008).
CCR5 has chemokine ligands that
reflect its natural role within the im-
mune system: MIP-1a (CCL3), MIP-1b
(CCL4), and RANTES (CCL5). CCL3L1
and CCL4L1 are variant chemokines
encoded by genes with varying copy
numbers. These chemokines inhibit
CCR5 use by HIV-1 through allosteric
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n cell-mediated immunity as a
es of the CCR5-CCL3L1 axis on
blockade and receptor downmodula-
tion (Figure 1) (Hartley et al., 2005);
the more chemokines present, the less
HIV-1 replicates. Genetic studies show
that the number of CCL3L1 gene
copies, and hence CCL3L1 expression
levels, influences disease progression
(Gonzalez et al., 2005).
But the CCR5-CCL3L1 system also
has other effects on disease progres-
sion. In a major new study in a re-
cent issue of Nature Immunology, over
2000 HIV-1-infected and control indi-
viduals were categorized by CCR5
genotype and CCL3L1 copy number
(Dolan et al., 2007). The combination
of a CCR5 high-expression genotype
with a low CCL3L1 copy number was
designated a high genetic risk; the
converse (low CCR5, high CCL3L1)
was designated a low risk. A high
CCR5-expression genotype com-
bined with a high CCL3L1 copy num-
ber, or low CCR5 with low CCL3L1,
constituted moderate risk categories.
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